Komatsu Nobukazu 小松誠和

… Alternative Names

小松誠和コマツノブカズ

KOMATSU Masakazu 小松誠和

Less

Researcher Number	50343687
Other IDs
Affiliation (Current)	2024: 久留米大学, 医学部, 准教授
Affiliation (based on the past Project Information) *help	2022: 久留米大学, 医学部, 准教授 2021: 久留米大学, 医学部, 講師 2011 – 2019: 久留米大学, 医学部, 講師 2006 – 2007: 久留米大学, 医学部, 講師 2003: 久留米大, 研究員 2002: 久留米大学, 先端癌治療研究センター, 研究員
Review Section/Research Field	Principal Investigator Basic Section 56050:Otorhinolaryngology-related / Pediatrics / Immunology / 膠原病・アレルギー・感染症内科学 / Digestive surgery Except Principal Investigator Gastroenterology / General surgery / Urology
Keywords	Principal Investigator 抗体 / 免疫学 / 再発転移頭頸部癌 / 腫瘍関連B細胞 / 免疫チェックポイント阻害療法 / ニボルマブ / 炎症性サイトカイン / 抑制性サイトカイン / 臨床 / 単核球細胞 … More / B細胞の再構築 / TCRレパトア / 免疫フェノタイプ / BCRレパトア / T細胞受容体レパトア / B細胞受容体レパトア / リツキシマブ / B細胞 / ネフローゼ症候群 / pMHC / がんワクチン / ペプチド・MHC複合体 / ペプチド / スギ花粉 / 花粉症 / アレルギー・ぜんそく / 抗ペプチド抗体 … More Except Principal Investigator 細胞・組織 / 応用動物 / 内科 / 免疫学 / Ｐreg / 潰瘍性大腸炎 / インターロイキン10 / 制御性形質芽細胞 / インターロイキンー10 / マウスモデル / 炎症性腸疾患 / 制御性形質芽細胞Preg / 制御性B細胞Breg / ペプチドワクチン療法 / 癌免疫療法 / 乳癌 / がん免疫療法 / がんペプチドワクチン / ペプチドワクチン / がんﾍﾟﾌﾟﾁﾄﾞﾜｸﾁﾝ / 乳がん / バイオマーカー / ゲノム解析 / 遺伝子発現 / がんワクチン / 前立腺がん Less

再発転移頭頸部癌に対する免疫チェックポイント阻害療法が腫瘍関連B細胞に与える影響Principal Investigator
- Principal Investigator
  
  小松誠和
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 56050:Otorhinolaryngology-related
- Research Institution
  Kurume University
Involvement B cells in refractory nephrotic syndromePrincipal Investigator
- Principal Investigator
  
  Komatsu Nobukazu
- Project Period (FY)
  2017 – 2019
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Pediatrics
- Research Institution
  Kurume University
Role of regulatory plasmablasts pReg in colitis
- Principal Investigator
  
  MIZOGUCHI Atsushi
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Kurume University
Characteristics and biological function of anti-pMHC antibodyPrincipal Investigator
- Principal Investigator
  
  KOMATSU Nobukazu
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Immunology
- Research Institution
  Kurume University
Clinical feasibility of personalized peptide vaccination for metastatic breast cancer patients
- Principal Investigator
  
  TOH Uhi
- Project Period (FY)
  2011 – 2014
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General surgery
- Research Institution
  Kurume University
Genomic and epigenetic analysis for immune responses in patients with prostate cancer
- Principal Investigator
  
  NOGUCHI Masanori
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Urology
- Research Institution
  Kurume University
抗ペプチド抗体による花粉症の診断と減感作療法へ向けた基礎研究Principal Investigator
- Principal Investigator
  
  小松誠和
- Project Period (FY)
  2006 – 2007
- Research Category
  
  Grant-in-Aid for Young Scientists (A)
- Research Field
  
  膠原病・アレルギー・感染症内科学
- Research Institution
  Kurume University
大腸癌拒絶抗原由来ペプチドに対する血中1gG抗体の誘導機構及び抗腫瘍作用の解明Principal Investigator
- Principal Investigator
  
  小松誠和
- Project Period (FY)
  2002
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Digestive surgery
- Research Institution
  Kurume University

All 2022 2021 2020 2013 2012 2011 2007 2006 Other

All Journal Article Presentation Patent

[Journal Article] Bone marrow findings and examination of peripheral blood CD20 cells in late-onset neutropenia after rituximab administration for nephrotic syndrome2020
- Author(s)
  倉田悟子、田中征治、日吉祐介、荒木潤一郎、江﨑拓也、財津亜友子、小松誠和、久野敏
- Journal Title
  
  Japanese journal of pediatric nephrology
  
  Volume: 33 Issue: 1 Pages: 51-57
- DOI
  10.3165/jjpn.cr.2019.0160
- NAID
  130007831712
- ISSN
  0915-2245, 1881-3933
- Language
  Japanese
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17K10165
[Journal Article] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases2013
- Author(s)
  Matsueda, S., Komatsu, N., Kusumoto, K., Koga, S., Yamada, A., Kuromatsu, R., Yamada, S., Seki, R., Yutani, S., Shichijo, S., Mine, T., Fukuda, T., Okamura, T., Okuda, S., Sata, M., Honda, J., Kaji, M., Itoh, K., Sasada, T.
- Journal Title
  
  Developmental and Comparative Immunology
  
  Volume: 41 (1) Pages: 68-76
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25870992
[Journal Article] Personalized Peptide Vaccine as a Novel Immunotherapy Against Advanced Cancer2013
- Author(s)
  Komatsu, N., Matsueda, S., Noguchi, M., Yamada, A., Noguchi, M., Itoh, K., Sasada, T.
- Journal Title
  
  Molecular Vaccines
  
  Volume: Part IV Pages: 361-369
- Data Source
  KAKENHI-PROJECT-25870992
[Journal Article] Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein2013
- Author(s)
  Komatsu, N., Jackson, H.M., Chan, K.-F., Oveissi, S., Cebon, J., Itoh, K., Chen, W.
- Journal Title
  
  Molecular Immunology
  
  Volume: 54 (3-4) Pages: 465-471
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25870992
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012
- Author(s)
  Komatsu N, Noguchi M, et al
- Journal Title
  
  Cancer
  
  Volume: (In press) Issue: 12 Pages: 3208-3221
- DOI
  10.1002/cncr.26636
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22591782, KAKENHI-PROJECT-23501292, KAKENHI-PROJECT-23591913
[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.2012
- Author(s)
  Komatsu N, Matsueda S, Tashiro K, IojiT, Shichijo S, Noguchi M, Suekane S, Moriya F, Matsuoka K, Kuhara S, Itoh K, Sasada T.
- Journal Title
  
  Cancer
  
  Volume: 15 Pages: 3208-3221
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] A phase I study of personalized peptide vaccination for advanced urothelial carcinoma patients who failed treatment with methotrexate, vinblastine, adriamycin and cisplatin.2011
- Author(s)
  Matsumoto K, Noguchi M, Satoh T, Tabata K, Fujita T, Iwamura M, Yamada A, Komatsu N, Baba S, Itoh K.
- Journal Title
  
  BJU Int
  
  Volume: 108 Pages: 831-838
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Phase I clinical study of a personalized peptide vaccination available for six different human leukocyte antigen (HLA-A2, -A3, -A11, -A24,-A31 and -A33)-positive patients with advanced cancer.2011
- Author(s)
  Yamada A, Noguchi M, Komatsu N, Suekane S, Yutani S, Moriya F, Mine T, Momozono K, Kawano K, Itoh K.
- Journal Title
  
  Experimental and therapeutic medicine
  
  Volume: 2 Pages: 109-117
- Data Source
  KAKENHI-PROJECT-22591782
[Journal Article] Assessment of immunological biomarkers in patients with advanced cancer treated by personalized peptide vaccination.2011
- Author(s)
  Noguchi M, Mine T, Komatsu N, Suekane S, Moriya F, Matsuoka K, Yutani S, Shichijo S, Yamada A, Toh Uhi, Kawano K, Azuma K, Uemura H, Okuno K, Matsumoto K, Yanagimoto H, Yamanaka R, Oka M, Todo S, Sasada T, Itoh K.
- Journal Title
  
  Cancer Biology & Therapy
  
  Volume: 12 Pages: 1266-79
- Data Source
  KAKENHI-PROJECT-22591782
[Patent] スギ花粉症の診断方法2006
- Inventor(s)
  伊東恭悟, 原田守, 小松誠和, 大久保公康
- Industrial Property Rights Holder
  久留米大学, 日本医科大学
- Industrial Property Number
  2006-028853
- Filing Date
  2006-10-24
- Data Source
  KAKENHI-PROJECT-18689025
[Presentation] The change of some cytokine levels during immune-checkpoint inhibitor treatment in R/M head and neck cancer patients2022
- Author(s)
  Nobukazu Komatsu, Takeharu Ono, Kanako Yokomizo, Akira Yamada, Hirohito Umeno
- Organizer
  第81回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K09595
[Presentation] NY-ESO-1 に対する抗体は再発転移頭頸部がんの抗 PD-1 抗体療法後の PFS を予測する2021
- Author(s)
  小松誠和、小野剛治、梅野博仁、山田亮
- Organizer
  第80回　日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-21K09595
[Presentation] スギ花粉症患者の花粉抗原に対する抗体の応答と臨床症状の相関2007
- Author(s)
  小松誠和, 七條茂樹, 伊東恭悟
- Organizer
  BMB2007
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2007-12-13
- Data Source
  KAKENHI-PROJECT-18689025
[Presentation] Recent advances of peptide-based cancer vaccine
- Author(s)
  Itoh K, Noguchi M, Yamada A, Shichijo S, Sasada T, Matsueda S, Komatsu N.
- Organizer
  第73回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Year and Date
  2014-09-25 – 2014-09-27
- Data Source
  KAKENHI-PROJECT-25870992

1. SEKI Naoko (40226634)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. NOGUCHI Masanori (10140691)

# of Collaborated Projects: 1 results

# of Collaborated Products: 5 results
3. MORIYA Fukuko (80449917)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
4. TOH Uhi (60268901)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. MIZOGUCHI Atsushi (50258472)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
6. 田中征治 (20389282)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
7. 小野剛治 (70449916)

# of Collaborated Projects: 1 results

# of Collaborated Products: 2 results

Komatsu Nobukazu 小松 誠和

小松 誠和 コマツ ノブカズ

KOMATSU Masakazu 小松 誠和

Research Projects

Research Products

Co-Researchers

再発転移頭頸部癌に対する免疫チェックポイント阻害療法が腫瘍関連B細胞に与える影響Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Involvement B cells in refractory nephrotic syndromePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Role of regulatory plasmablasts pReg in colitis

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Characteristics and biological function of anti-pMHC antibodyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Clinical feasibility of personalized peptide vaccination for metastatic breast cancer patients

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Genomic and epigenetic analysis for immune responses in patients with prostate cancer

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

抗ペプチド抗体による花粉症の診断と減感作療法へ向けた基礎研究Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

大腸癌拒絶抗原由来ペプチドに対する血中1gG抗体の誘導機構及び抗腫瘍作用の解明Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Bone marrow findings and examination of peripheral blood CD20 cells in late-onset neutropenia after rituximab administration for nephrotic syndrome2020

Author(s)

Journal Title

DOI

NAID

ISSN

Language

Data Source

[Journal Article] Humoral immune responses to CTL epitope peptides from tumor-associated antigens are widely detectable in humans: A new biomarker for overall survival of patients with malignant diseases2013

Author(s)

Journal Title

Data Source

[Journal Article] Personalized Peptide Vaccine as a Novel Immunotherapy Against Advanced Cancer2013

Author(s)

Journal Title

Data Source

[Journal Article] Fine-mapping naturally occurring NY-ESO-1 antibody epitopes in melanoma patients' sera using short overlapping peptides and full-length recombinant protein2013

Author(s)

Journal Title

Data Source

[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination2012

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Gene expression profiles in peripheral blood as a biomarker in cancer patients receiving peptide vaccination.2012

Komatsu Nobukazu 小松誠和

小松誠和コマツノブカズ

KOMATSU Masakazu 小松誠和

[Presentation] NY-ESO-1 に対する抗体は再発転移頭頸部がんの抗 PD-1 抗体療法後の PFS を予測する2021